Skip to content
ppharmaranks
Menu
Class IIOngoing

KIRKLAND Signature recall

FDA recall D-0557-2026 · initiated May 28, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jun 10, 2026How we research

Guardian Drug Co. Inc. recalled KIRKLAND Signature in May 2026 — an FDA Class II recall (D-0557-2026) because Presence of foreign substance: small metallic particles in chewable tablets.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Presence of foreign substance: small metallic particles in chewable tablets.

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot#: 1716059, 1716060, 1716061, 1716062, 1716063, 1716218, 1716219, 1716228, 1716229, 1716238, Exp 2/28/2029; 1716258, Exp 3/31/2029.

Details

Product
KIRKLAND Signature, ULTRA STRENGTH ANTACID, Calcium Carbonate, 1000 mg, 265-count bottle, MANUFACTURED BY: GUARDIAN DRUG COMPANY, INC., 2 CHARLES COURT/DAYTON, NJ 08810, FOR: Costco Wholesale Corporation, 999 Lake Drive, Issaquah, WA 98027, NDC 63981-171-80
Recalling company
Guardian Drug
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
U.S.A. Nationwide
Initiated
May 28, 2026
FDA report date
Jun 10, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was KIRKLAND Signature recalled?
Guardian Drug Co. Inc. recalled KIRKLAND Signature in May 2026 — an FDA Class II recall (D-0557-2026) because Presence of foreign substance: small metallic particles in chewable tablets. May cause temporary or medically reversible harm; low probability of serious harm.
Why was KIRKLAND Signature recalled?
Per the FDA enforcement record, the reason for recall D-0557-2026 was: Presence of foreign substance: small metallic particles in chewable tablets.
Is a recalled KIRKLAND Signature dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of KIRKLAND Signature are affected?
Distributed: U.S.A. Nationwide. The recall covers these lots — Lot#: 1716059, 1716060, 1716061, 1716062, 1716063, 1716218, 1716219, 1716228, 1716229, 1716238, Exp 2/28/2029; 1716258, Exp 3/31/2029.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0557-2026.

Source: openFDA Drug Enforcement record D-0557-2026

← All drug recalls